Biomx Ltd (PHGE)

$0.42 -0.05 (-9.75%)
Market Cap 5.15M
Revenue (ttm) 0.00
Net Income (ttm) -36.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 334,000
Avg Vol 7,632,386
Day's Range N/A - N/A
Shares Out 11.16M
Stochastic %K 1%
Beta 1.18
Analysts Hold
Price Target $26.00

Company Profile

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.

Industry: Aerospace & Defense
Sector: Industrials
Address:
850 New Burton Road, Suite 201, Dover, United States
forsiz1
forsiz1 Jun. 25 at 1:55 AM
$PHGE Any hope? 🙏
0 · Reply
simplifocused
simplifocused Jun. 24 at 5:47 PM
$PHGE where is the captain of this ship?
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Jun. 23 at 3:47 AM
$PHGE told you it would keep going down
0 · Reply
jctataio
jctataio Jun. 22 at 11:00 PM
$PHGE annual meeting on 26th June 2026 https://ir.biomx.com/static-files/96dd8292-eb2b-4d5b-aff1-4fb9184d4183
0 · Reply
forsiz1
forsiz1 Jun. 21 at 8:33 AM
$PHGE $1.X Monday? Great defense startegy with all the right people in management 👏 I will sell at $10 $$$$$$$
0 · Reply
kamenrider888
kamenrider888 Jun. 21 at 4:03 AM
$PHGE like i said when it was $6...scam stock FLATILINED will reverse stock split into infinity..
0 · Reply
kamenrider888
kamenrider888 Jun. 20 at 5:46 AM
$PHGE scam stock from $6 to 50cents as predicted lmao
0 · Reply
focafoca99
focafoca99 Jun. 18 at 1:41 PM
$PHGE released an updated presentation detailing its defense‑technology portfolio and growth strategy.
0 · Reply
MrTicker
MrTicker Jun. 18 at 1:17 PM
$PHGE BiomX Provides Update on Defense Technology Portfolio and Growth StrategyPresentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats GLOBENEWSWIRE 8:15 AM ET 6/18/2026
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Jun. 18 at 3:36 AM
$PHGE it’s not done going down yet
0 · Reply
Latest News on PHGE
BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026

Jun 24, 2026, 8:38 AM EDT - 23 hours ago

BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026

BiomX Proxy statement: Proxy filing

Jun 22, 2026, 8:00 AM EDT - 3 days ago

BiomX Proxy statement: Proxy filing

BiomX Provides Update on Defense Technology Portfolio and Growth Strategy

Jun 18, 2026, 9:15 AM EDT - 6 days ago

BiomX Provides Update on Defense Technology Portfolio and Growth Strategy

BiomX Slides: Investor presentation

Jun 15, 2026, 7:00 AM EDT - 10 days ago

BiomX Slides: Investor presentation

BiomX announces acceptance of plan to regain compliance with NYSE

2026-06-12T13:16:16.000Z - 12 days ago

BiomX announces acceptance of plan to regain compliance with NYSE

BiomX Announces NYSE American Acceptance of Plan to Regain Compliance

Jun 12, 2026, 9:00 AM EDT - 12 days ago

BiomX Announces NYSE American Acceptance of Plan to Regain Compliance

BiomX: Zorronet's AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events

Jun 11, 2026, 9:03 AM EDT - 13 days ago

BiomX: Zorronet's AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events

BiomX Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 17 days ago

BiomX Proxy statement: Proxy filing

BiomX appoints Gabby Sarusi as strategic advisor

2026-06-02T13:56:30.000Z - 22 days ago

BiomX appoints Gabby Sarusi as strategic advisor

Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit

Jun 2, 2026, 9:32 AM EDT - 22 days ago

Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit

Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence

Jun 1, 2026, 9:25 AM EDT - 23 days ago

Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence

BiomX names Roy Timor-Rousso as Chief Business Officer

2026-05-27T15:22:44.000Z - 4 weeks ago

BiomX names Roy Timor-Rousso as Chief Business Officer

BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations

May 27, 2026, 9:40 AM EDT - 4 weeks ago

BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations

BiomX Quarterly report: Q1 2026

May 20, 2026, 4:00 PM EDT - 5 weeks ago

BiomX Quarterly report: Q1 2026

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

May 6, 2026, 4:15 PM EDT - 7 weeks ago

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

Apr 16, 2026, 4:30 PM EDT - 2 months ago

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Apr 13, 2026, 9:20 AM EDT - 2 months ago

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

Apr 10, 2026, 8:30 AM EDT - 2 months ago

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

Biomx Inc trading halted, news pending

2026-04-09T18:36:16.000Z - 2 months ago

Biomx Inc trading halted, news pending

Biomx Inc trading resumes

2026-04-01T14:10:15.000Z - 3 months ago

Biomx Inc trading resumes

Biomx Inc trading halted, news pending

2026-04-01T13:38:15.000Z - 3 months ago

Biomx Inc trading halted, news pending

BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

Mar 31, 2026, 10:48 AM EDT - 3 months ago

BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

BiomX Adds Former Mossad Deputy to Advisory Board

Mar 30, 2026, 9:28 AM EDT - 3 months ago

BiomX Adds Former Mossad Deputy to Advisory Board

BiomX receives noncompliance notification from Nasdaq

2026-03-27T20:40:15.000Z - 3 months ago

BiomX receives noncompliance notification from Nasdaq

BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

Mar 27, 2026, 4:30 PM EDT - 3 months ago

BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

BiomX launches X Security & Defense subsidiary in Israel

2026-03-26T13:08:14.000Z - 3 months ago

BiomX launches X Security & Defense subsidiary in Israel

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

Mar 26, 2026, 8:48 AM EDT - 3 months ago

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

BiomX Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 3 months ago

BiomX Proxy statement: Proxy filing

BiomX issues letter to shareholders

2026-03-19T13:20:44.000Z - 3 months ago

BiomX issues letter to shareholders

BiomX CEO Issues Letter to Stockholders

Mar 19, 2026, 9:15 AM EDT - 3 months ago

BiomX CEO Issues Letter to Stockholders

BiomX Transcript: EGM 2026

Mar 11, 2026, 8:00 AM EDT - 3 months ago

BiomX Transcript: EGM 2026

BiomX downgraded to Neutral from Buy at H.C. Wainwright

2026-03-09T14:55:29.000Z - 3 months ago

BiomX downgraded to Neutral from Buy at H.C. Wainwright

BiomX names Michael Oster as CEO, David Rokach as CFO

2026-03-09T13:07:20.000Z - 3 months ago

BiomX names Michael Oster as CEO, David Rokach as CFO

BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

Mar 9, 2026, 9:00 AM EDT - 3 months ago

BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

Biomx Inc trading resumes

2026-03-05T16:00:36.000Z - 3 months ago

Biomx Inc trading resumes

Biomx Inc trading halted, volatility trading pause

2026-03-05T15:55:32.000Z - 3 months ago

Biomx Inc trading halted, volatility trading pause

BiomX Transcript: EGM 2026

Feb 25, 2026, 8:00 AM EST - 4 months ago

BiomX Transcript: EGM 2026

BiomX Annual report: Q4 2025

Feb 19, 2026, 7:00 AM EST - 4 months ago

BiomX Annual report: Q4 2025

BiomX Proxy statement: Proxy Filing

Feb 13, 2026, 7:00 AM EST - 4 months ago

BiomX Proxy statement: Proxy Filing

BiomX files to sell 5.31M shares of common stock for holders

2026-02-09T21:40:33.000Z - 4 months ago

BiomX files to sell 5.31M shares of common stock for holders

BiomX Registration statement: Registration Filing

Feb 9, 2026, 7:00 AM EST - 4 months ago

BiomX Registration statement: Registration Filing

BiomX Proxy statement: Proxy Filing

Feb 3, 2026, 7:00 AM EST - 5 months ago

BiomX Proxy statement: Proxy Filing

Biomx Inc trading resumes

2026-01-29T14:50:55.000Z - 5 months ago

Biomx Inc trading resumes

Biomx Inc trading halted, volatility trading pause

2026-01-29T14:46:29.000Z - 5 months ago

Biomx Inc trading halted, volatility trading pause

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

Jan 27, 2026, 1:41 PM EST - 5 months ago

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

BiomX announces $3M private placement

2025-12-29T13:15:13.000Z - 6 months ago

BiomX announces $3M private placement

BiomX Announces $3.0 Million Private Placement

Dec 29, 2025, 8:00 AM EST - 6 months ago

BiomX Announces $3.0 Million Private Placement

BiomX discontinues Phase 2b BX004 trial, plans cost-cutting measures

2025-12-08T12:36:04.000Z - 7 months ago

BiomX discontinues Phase 2b BX004 trial, plans cost-cutting measures

BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis

2025-11-25T21:45:24.000Z - 7 months ago

BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

Nov 25, 2025, 4:40 PM EST - 7 months ago

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

BiomX Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Earnings Call Transcript: Q3 2025

BiomX Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Quarterly report: Q3 2025

BiomX Earnings release: Q3 2025

Nov 12, 2025, 8:30 AM EST - 8 months ago

BiomX Earnings release: Q3 2025

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Nov 12, 2025, 7:30 AM EST - 8 months ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Oct 17, 2025, 8:30 AM EDT - 8 months ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

BiomX Proxy statement: Proxy Filing

Aug 28, 2025, 8:00 AM EDT - 10 months ago

BiomX Proxy statement: Proxy Filing

BiomX Proxy statement: Proxy Filing

Aug 28, 2025, 8:00 AM EDT - 10 months ago

BiomX Proxy statement: Proxy Filing

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 19, 2025, 8:19 AM EDT - 11 months ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

BiomX Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 11 months ago

BiomX Proxy statement: Proxy Filing

BiomX Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Earnings Call Transcript: Q2 2025

BiomX Quarterly report: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Quarterly report: Q2 2025

BiomX Earnings release: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 11 months ago

BiomX Earnings release: Q2 2025

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 13, 2025, 6:30 AM EDT - 11 months ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Aug 6, 2025, 8:30 AM EDT - 11 months ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 14, 2025, 9:00 AM EDT - 1 year ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 1 year ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 19, 2025, 10:02 AM EDT - 1 year ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

BiomX Earnings Call Transcript: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings Call Transcript: Q1 2025

BiomX Quarterly report: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Quarterly report: Q1 2025

BiomX Earnings release: Q1 2025

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings release: Q1 2025

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 15, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

BiomX Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

BiomX Registration statement: Registration Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

BiomX Registration statement: Registration Filing

BiomX Transcript: KOL Event

Apr 3, 2025, 11:00 AM EDT - 1 year ago

BiomX Transcript: KOL Event

BiomX Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Apr 1, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

BiomX Earnings Call Transcript: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q4 2024

BiomX Annual report: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Annual report: Q4 2024

BiomX Earnings release: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings release: Q4 2024

BiomX Slides: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Slides: Q4 2024

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 31, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

BiomX Proxy statement: Proxy Filing

Mar 27, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 25, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Mar 19, 2025, 12:35 PM EDT - 1 year ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

BiomX Proxy statement: Proxy Filing

Mar 17, 2025, 8:00 AM EDT - 1 year ago

BiomX Proxy statement: Proxy Filing

BiomX Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings Call Transcript: Q3 2024

BiomX Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Quarterly report: Q3 2024

BiomX Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings release: Q3 2024

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

BiomX Announces a Mandatory Unit Separation

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 18, 2024, 8:00 AM EDT - 1 year ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

BiomX Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024, 7:00 AM EDT - 1 year ago

BiomX Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 16, 2024, 10:55 AM EDT - 2 years ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Earnings Call Transcript: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q2 2024

BiomX Quarterly report: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Quarterly report: Q2 2024

BiomX Earnings release: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings release: Q2 2024

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 15, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 29, 2024, 7:00 AM EDT - 2 years ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

BiomX Registration statement: Registration Filing

Jul 11, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

Jul 10, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

BiomX Registration statement: Registration Filing

Jul 9, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

BiomX Proxy statement: Proxy Filing

Jun 17, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

BiomX Proxy statement: Proxy Filing

Jun 13, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

May 30, 2024, 4:50 PM EDT - 2 years ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

May 30, 2024, 7:00 AM EDT - 2 years ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

BiomX Proxy statement: Proxy Filing

May 28, 2024, 8:00 AM EDT - 2 years ago

BiomX Proxy statement: Proxy Filing

BiomX Earnings Call Transcript: Q1 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q1 2024

BiomX Earnings release: Q1 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings release: Q1 2024

BiomX Quarterly report: Q1 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Quarterly report: Q1 2024

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

May 21, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

BiomX Registration statement: Registration Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

BiomX Registration statement: Registration Filing

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Apr 23, 2024, 8:00 AM EDT - 2 years ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

forsiz1
forsiz1 Jun. 25 at 1:55 AM
$PHGE Any hope? 🙏
0 · Reply
simplifocused
simplifocused Jun. 24 at 5:47 PM
$PHGE where is the captain of this ship?
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Jun. 23 at 3:47 AM
$PHGE told you it would keep going down
0 · Reply
jctataio
jctataio Jun. 22 at 11:00 PM
$PHGE annual meeting on 26th June 2026 https://ir.biomx.com/static-files/96dd8292-eb2b-4d5b-aff1-4fb9184d4183
0 · Reply
forsiz1
forsiz1 Jun. 21 at 8:33 AM
$PHGE $1.X Monday? Great defense startegy with all the right people in management 👏 I will sell at $10 $$$$$$$
0 · Reply
kamenrider888
kamenrider888 Jun. 21 at 4:03 AM
$PHGE like i said when it was $6...scam stock FLATILINED will reverse stock split into infinity..
0 · Reply
kamenrider888
kamenrider888 Jun. 20 at 5:46 AM
$PHGE scam stock from $6 to 50cents as predicted lmao
0 · Reply
focafoca99
focafoca99 Jun. 18 at 1:41 PM
$PHGE released an updated presentation detailing its defense‑technology portfolio and growth strategy.
0 · Reply
MrTicker
MrTicker Jun. 18 at 1:17 PM
$PHGE BiomX Provides Update on Defense Technology Portfolio and Growth StrategyPresentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats GLOBENEWSWIRE 8:15 AM ET 6/18/2026
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Jun. 18 at 3:36 AM
$PHGE it’s not done going down yet
0 · Reply
TCzeck
TCzeck Jun. 16 at 2:42 PM
$PHGE This week ⏰
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 15 at 12:25 PM
$PHGE bounce
0 · Reply
bulls4money
bulls4money Jun. 14 at 10:36 PM
$PHGE GMM top list on PM AND 100-1000% + meme stock squeeze potential tomorrow 👀👀👀🚀🚀
0 · Reply
TCzeck
TCzeck Jun. 12 at 9:07 PM
$PHGE Looks to hold strength for next week! Floor has been discovered 🙌🏻
0 · Reply
TCzeck
TCzeck Jun. 12 at 8:06 PM
$PHGE Order book spread is insane 😅 .53-.88 with active trading. Woofta!
0 · Reply
TCzeck
TCzeck Jun. 12 at 7:58 PM
$PHGE ⏰
0 · Reply
Saif1993
Saif1993 Jun. 12 at 6:35 PM
$PHGE shorted sooooo much gonna squeeze hard
1 · Reply
Paulus1930
Paulus1930 Jun. 12 at 6:26 PM
$AMZE $DFNS $PHGE better luck tonight
0 · Reply
DragonOfBosnia
DragonOfBosnia Jun. 12 at 6:15 PM
$AMZE $DFNS $PHGE hope some of the bag holders got out of this… DFNS Israel stock scam..
1 · Reply
forsiz1
forsiz1 Jun. 12 at 5:56 PM
$PHGE Why is it down today???
1 · Reply
TCzeck
TCzeck Jun. 12 at 5:32 PM
$PHGE .51 perfect buying zone 👌🏻
1 · Reply
Humpty_Pumpty
Humpty_Pumpty Jun. 12 at 5:13 PM
$DFNS this is why the stock is not where most people believe it should be. Ongoing lawsuit, predatory financing, only 2 revenue drivers (Rimon and Tiltan), confusing capital structure (check out how Menny is related to $PHGE and the Zorronet sale), CEO has a massive salary, and company is burning through cash. @Will3732 what's your bull thesis?
0 · Reply